We describe a case of 13-year-old female with intermittent asthma who developed lactic acidosis and diastolic hypotension after receiving intermittent albuterol nebulizer treatment.
Tehila A. Saadia +2 more
doaj +2 more sources
Objective Albuterol is a β2‐agonist and causes an intracellular shift of potassium from the interstitium. Whole‐body hypokalemia is known to cause skeletal muscle weakness, but whether this occurs as a result of hypokalemia from the intracellular shift ...
Catherine Burger +2 more
doaj +2 more sources
Limiting Albuterol Use by EMS at the Start of the COVID-19 Pandemic: A Retrospective Analysis of Rapid Deimplementation [PDF]
Introduction: Deimplementation is the process through which an existing practice, procedure, or protocol is discontinued. Past deimplementation efforts in emergency medical services (EMS), such as reduction of liberal oxygen administration, backboard use,
Renoj Varughese +7 more
doaj +2 more sources
Exhaled Breath Condensate Detects Baseline Reductions in Chloride and Increases in Response to Albuterol in Cystic Fibrosis Patients [PDF]
Impaired ion regulation and dehydration is the primary pathophysiology in cystic fibrosis (CF) lung disease. A potential application of exhaled breath condensate (EBC) collection is to assess airway surface liquid ionic composition at baseline and in ...
Courtney M. Wheatley +7 more
doaj +2 more sources
Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease [PDF]
David B Price,1,2 Anna Rigazio,2 Mary Buatti Small,3 Thomas J Ferro,3 1Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK; 2Research in Real-Life Ltd, Cambridge, UK; 3Teva Pharmaceuticals, Frazer, PA, USA ...
Price DB +3 more
doaj +3 more sources
Effects of the ß2-Adrenoceptor Agonist, Albuterol, in a Mouse Model of Anti-MuSK Myasthenia Gravis [PDF]
The β2-adrenergic receptor agonist, albuterol, has been reported beneficial in treating several forms of congenital myasthenia. Here, for the first time, we examined the potential benefit of albuterol in a mouse model of anti-Muscle Specific Kinase (MuSK)
Marco Morsch, Nigel Tse
exaly +2 more sources
Albuterol Use in Children Hospitalized with Human Metapneumovirus Respiratory Infection [PDF]
Introduction. Human metapneumovirus (HMPV) is a paramyxovirus from the same subfamily as respiratory syncytial virus (RSV) and causes similar acute lower respiratory tract infection.
Lindsey K. Rasmussen +2 more
doaj +2 more sources
Assessing the cardiovascular and potassium lowering effects of levalbuterol compared to albuterol: a randomized control trial [PDF]
BackgroundBeta-agonists like Levalbuterol and Albuterol are used in the treatment of Hyperkalemia. However, few studies in the medical literature have directly compared the cardiac effects and potassium-lowering efficacy of levalbuterol and albuterol ...
Baraa Shebli +5 more
doaj +2 more sources
A 10-year interval of cardiovascular effects of albuterol in asthma management: Graphical review [PDF]
Asthma is a widespread chronic respiratory disease that requires effective management to reduce exacerbations and improve patient outcomes. Albuterol (salbutamol), a short-acting beta-2-agonist (SABA), remains a mainstay treatment for acute symptom ...
Ghulam H. Abbas +6 more
doaj +2 more sources
Optimization of Albuterol Delivery via Anesthesia Bag in Pediatric Critical Care [PDF]
Background/Objectives: Aerosolized medications are common practice for mechanically ventilated pediatric patients. Infants often receive nebulized medications via hand ventilation using an anesthesia bag, but evidence on optimal aerosol delivery with ...
Sébastien Tessier +5 more
doaj +2 more sources

